Search by Drug Name or NDC

    NDC 45737-0221-16 Biodesp 15; 100; 5 mg/5mL; mg/5mL; mg/5mL Details

    Biodesp 15; 100; 5 mg/5mL; mg/5mL; mg/5mL

    Biodesp is a ORAL LIQUID in the HUMAN OTC DRUG category. It is labeled and distributed by Advanced Generic Corporation. The primary component is DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 45737-0221
    Product ID 45737-221_fe676580-acff-42f8-bc7a-076af73dd1b4
    Associated GPIs 43997303101211
    GCN Sequence Number 051230
    GCN Sequence Number Description guaifen/dextromethorphan/PE LIQUID 100-15-5/5 ORAL
    HIC3 B4R
    HIC3 Description NON-OPIOID ANTITUSSIVE-DECONGESTANT-EXPECTORANT
    GCN 18409
    HICL Sequence Number 000216
    HICL Sequence Number Description GUAIFENESIN/DEXTROMETHORPHAN HBR/PHENYLEPHRINE
    Brand/Generic Generic
    Proprietary Name Biodesp
    Proprietary Name Suffix DM
    Non-Proprietary Name Dextromethorphan, Guaifenesin, Phenylephrine
    Product Type HUMAN OTC DRUG
    Dosage Form LIQUID
    Route ORAL
    Active Ingredient Strength 15; 100; 5
    Active Ingredient Units mg/5mL; mg/5mL; mg/5mL
    Substance Name DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name Advanced Generic Corporation
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2024-12-31

    Package

    NDC 45737-0221-16 (45737022116)

    NDC Package Code 45737-221-16
    Billing NDC 45737022116
    Package 473 mL in 1 BOTTLE (45737-221-16)
    Marketing Start Date 2009-01-01
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 6b303f1a-0a8b-43a9-bb31-d5a0d46becc7 Details

    Revised: 12/2020